Fukagawa M - Search Results

1

Corrigendum to "Efficacy of evocalcet in previously cinacalcet-treated secondary hyperparathyroidism patients," [Kidney Int. Rep. 2021; https://doi.org/10.1016/j.ekir.2021.08.020].

Koiwa F, Tokunaga S, Asada S, Endo Y, Fukagawa M, Akizawa T. Koiwa F, et al. Among authors: fukagawa m. Kidney Int Rep. 2021 Nov 5;6(11):2936-2937. doi: 10.1016/j.ekir.2021.09.011. eCollection 2021 Nov. Kidney Int Rep. 2021. PMID: 34826317 Free PMC article.

2

Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients.

Fukagawa M, Kitaoka M, Tominaga Y, Akizawa T, Kakuta T, Onoda N, Koiwa F, Yumita S, Kurokawa K; Japanese Society for Parathyroid Intervention. Fukagawa M, et al. Nephrol Dial Transplant. 2003 Jun;18 Suppl 3:iii31-3. doi: 10.1093/ndt/gfg1008. Nephrol Dial Transplant. 2003. PMID: 12771296

3

Extracorporeal albumin dialysis.

Abe T, Shono M, Kodama T, Kita Y, Fukagawa M, Akizawa T. Abe T, et al. Among authors: fukagawa m. Ther Apher Dial. 2004 Jun;8(3):217-22. doi: 10.1111/j.1526-0968.2004.00148.x. Ther Apher Dial. 2004. PMID: 15154874

4

How to apply and adapt international guidelines on bone metabolism and disease to the management of Japanese dialysis patients.

Fukagawa M, Akizawa T. Fukagawa M, et al. Ther Apher Dial. 2005 Feb;9(1):1-2. doi: 10.1111/j.1774-9987.2005.00204.x. Ther Apher Dial. 2005. PMID: 15828896 No abstract available.

5

Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblast growth factor 23 levels in dialysis patients.

Koiwa F, Kazama JJ, Tokumoto A, Onoda N, Kato H, Okada T, Nii-Kono T, Fukagawa M, Shigematsu T; ROD21 Clinical Research Group. Koiwa F, et al. Among authors: fukagawa m. Ther Apher Dial. 2005 Aug;9(4):336-9. doi: 10.1111/j.1744-9987.2005.00293.x. Ther Apher Dial. 2005. PMID: 16076378 Clinical Trial.

6

Calcium abnormalities of dialysis patients.

Fukagawa M, Akizawa T. Fukagawa M, et al. J Bone Miner Metab. 2006;24(2):160. doi: 10.1007/s00774-005-0663-y. J Bone Miner Metab. 2006. PMID: 16502124 Review. No abstract available.

7

[Role of the kidney in mineral metabolism].

Fukagawa M, Akizawa T. Fukagawa M, et al. Nihon Jinzo Gakkai Shi. 2007;49(4):404-5. Nihon Jinzo Gakkai Shi. 2007. PMID: 17578183 Japanese. No abstract available.

8

Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favorable control of the serum phosphorus and calcium levels in Japanese dialysis patients.

Fukagawa M, Yumita S, Akizawa T, Uchida E, Tsukamoto Y, Iwasaki M, Koshikawa S; KRN1493 study group. Fukagawa M, et al. Nephrol Dial Transplant. 2008 Jan;23(1):328-35. doi: 10.1093/ndt/gfm534. Epub 2007 Aug 23. Nephrol Dial Transplant. 2008. PMID: 17717030 Clinical Trial.

9

Direct injection of calcitriol or its analog improves abnormal gene expression in the hyperplastic parathyroid gland in uremia.

Shiizaki K, Fukagawa M, Yuan Q, Hatamura I, Nii-Kono T, Saji F, Shigematsu T, Akizawa T. Shiizaki K, et al. Among authors: fukagawa m. Am J Nephrol. 2008;28(1):59-66. doi: 10.1159/000109240. Epub 2007 Sep 28. Am J Nephrol. 2008. PMID: 17901691

10

Revised equations for estimated GFR from serum creatinine in Japan.

Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A; Collaborators developing the Japanese equation for estimated GFR. Matsuo S, et al. Am J Kidney Dis. 2009 Jun;53(6):982-92. doi: 10.1053/j.ajkd.2008.12.034. Epub 2009 Apr 1. Am J Kidney Dis. 2009. PMID: 19339088

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

621 results

Search Page

Filters